These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

419 related items for PubMed ID: 15135892

  • 1. Comparative effects of huperzine A, donepezil and rivastigmine on cortical acetylcholine level and acetylcholinesterase activity in rats.
    Liang YQ, Tang XC.
    Neurosci Lett; 2004 May 06; 361(1-3):56-9. PubMed ID: 15135892
    [Abstract] [Full Text] [Related]

  • 2. Comparative studies of huperzine A, donepezil, and rivastigmine on brain acetylcholine, dopamine, norepinephrine, and 5-hydroxytryptamine levels in freely-moving rats.
    Liang YQ, Tang XC.
    Acta Pharmacol Sin; 2006 Sep 06; 27(9):1127-36. PubMed ID: 16923332
    [Abstract] [Full Text] [Related]

  • 3. N1phenethyl-norcymserine, a selective butyrylcholinesterase inhibitor, increases acetylcholine release in rat cerebral cortex: a comparison with donepezil and rivastigmine.
    Cerbai F, Giovannini MG, Melani C, Enz A, Pepeu G.
    Eur J Pharmacol; 2007 Oct 31; 572(2-3):142-50. PubMed ID: 17643410
    [Abstract] [Full Text] [Related]

  • 4. Effects of huperzine A on acetylcholinesterase isoforms in vitro: comparison with tacrine, donepezil, rivastigmine and physostigmine.
    Zhao Q, Tang XC.
    Eur J Pharmacol; 2002 Nov 29; 455(2-3):101-7. PubMed ID: 12445575
    [Abstract] [Full Text] [Related]

  • 5. Sensitivity of butyrylcholinesterase knockout mice to (--)-huperzine A and donepezil suggests humans with butyrylcholinesterase deficiency may not tolerate these Alzheimer's disease drugs and indicates butyrylcholinesterase function in neurotransmission.
    Duysen EG, Li B, Darvesh S, Lockridge O.
    Toxicology; 2007 Apr 20; 233(1-3):60-9. PubMed ID: 17194517
    [Abstract] [Full Text] [Related]

  • 6. Regional effects of donepezil and rivastigmine on cortical acetylcholinesterase activity in Alzheimer's disease.
    Kaasinen V, Någren K, Järvenpää T, Roivainen A, Yu M, Oikonen V, Kurki T, Rinne JO.
    J Clin Psychopharmacol; 2002 Dec 20; 22(6):615-20. PubMed ID: 12454562
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of donepezil hydrochloride (E2020) on extracellular acetylcholine concentration in the cerebral cortex of rats.
    Kosasa T, Kuriya Y, Yamanishi Y.
    Jpn J Pharmacol; 1999 Oct 20; 81(2):216-22. PubMed ID: 10591480
    [Abstract] [Full Text] [Related]

  • 11. Changes in cerebral neurotransmitters and metabolites induced by acute donepezil and memantine administrations: a microdialysis study.
    Shearman E, Rossi S, Szasz B, Juranyi Z, Fallon S, Pomara N, Sershen H, Lajtha A.
    Brain Res Bull; 2006 Mar 31; 69(2):204-13. PubMed ID: 16533671
    [Abstract] [Full Text] [Related]

  • 12. A multinational, randomised, 12-week, comparative study of donepezil and rivastigmine in patients with mild to moderate Alzheimer's disease.
    Wilkinson DG, Passmore AP, Bullock R, Hopker SW, Smith R, Potocnik FC, Maud CM, Engelbrecht I, Hock C, Ieni JR, Bahra RS.
    Int J Clin Pract; 2002 Mar 31; 56(6):441-6. PubMed ID: 12166542
    [Abstract] [Full Text] [Related]

  • 13. Up-regulation of nicotinic acetylcholine receptors by central-type acetylcholinesterase inhibitors in rat cortical neurons.
    Kume T, Sugimoto M, Takada Y, Yamaguchi T, Yonezawa A, Katsuki H, Sugimoto H, Akaike A.
    Eur J Pharmacol; 2005 Dec 19; 527(1-3):77-85. PubMed ID: 16313899
    [Abstract] [Full Text] [Related]

  • 14. Reversible and persistent decreases in cocaine self-administration after cholinesterase inhibition: different effects of donepezil and rivastigmine.
    Grasing K, Yang Y, He S.
    Behav Pharmacol; 2011 Feb 19; 22(1):58-70. PubMed ID: 22173266
    [Abstract] [Full Text] [Related]

  • 15. Rivastigmine and donepezil treatment in moderate to moderately-severe Alzheimer's disease over a 2-year period.
    Bullock R, Touchon J, Bergman H, Gambina G, He Y, Rapatz G, Nagel J, Lane R.
    Curr Med Res Opin; 2005 Aug 19; 21(8):1317-27. PubMed ID: 16083542
    [Abstract] [Full Text] [Related]

  • 16. Inhibitory effect of orally administered donepezil hydrochloride (E2020), a novel treatment for Alzheimer's disease, on cholinesterase activity in rats.
    Kosasa T, Kuriya Y, Matsui K, Yamanishi Y.
    Eur J Pharmacol; 2000 Feb 18; 389(2-3):173-9. PubMed ID: 10688981
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Brain levels and acetylcholinesterase inhibition with galantamine and donepezil in rats, mice, and rabbits.
    Geerts H, Guillaumat PO, Grantham C, Bode W, Anciaux K, Sachak S.
    Brain Res; 2005 Feb 08; 1033(2):186-93. PubMed ID: 15694923
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.